Drugs innovator Indivior, with a market value of £2bn, wants to move to the US, joining firms seeking to quit London in search of a higher valuation.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.